PCR conditions were the following: initial denaturation at 94°C for 5 min; 35 cycles at 95°C for 30 s, 58°C for 30 s, and 72°C for 30 s; and fi nal incubation for 10 min at 72°C. Taq DNA polymerase and dNTPs from QIAGEN (Hilden, Germany) were used. The 264-bp fragment was sequenced and compared with the GenBank entry for NDM-1.
Carbapenemase-producing K. pneumoniae has been detected in 26 isolates obtained during September 2007 through August 2010 from 6 patients at the University Hospital, Graz, Austria. Eight isolates from 2 patients were found to carry the plasmid NDM-1. The fi rst case involving NDM-1 occurred in November 2009, and the second occurred in August 2010. Automated repetitive element PCR, conducted with the DiversiLab system (bioMérieux, Marcy l'Etoile, France) (6) showed a genetic relatedness of isolates from the 2 patients of ≤81.1% (5 band differences), which indicated independent clones. Isolated NDM-1 strains exhibited resistance to nearly all antibacterial agents, including aztreonam, ciprofl oxacin, and gentamicin, and were susceptible to only colistin, tigecycline, and amikacin (Table) .
Patient 1, a 30-year-old Austrian man, was admitted to University Hospital (Graz, Austria) in November 2009. His medical history showed he had experienced multiple open fractures of his upper and lower left leg as well as rectal laceration because of a motorcycle accident in Pakistan. His treatment had taken place primarily in surgery departments in Pakistan and India. During his hospitalization in Austria, multiple resistant gram-negative bacteria were isolated, including highly resistant NDM-1-producing K. pneumoniae. The NDM-1 strain was isolated twice, from a sacral decubitus ulcer and from stool. After 5 months of recurrent hospitalizations with various infectious complications, multiple anti-infective regimens, and surgical interventions required to treat fractures resulting from the patient's motorcycle accident, the patient was released without further medical problems.
In August 2010, patient 2, a 14-year-old boy from Kosovo, was transferred from a hospital in that country to the Department of Pediatrics, University Hospital (Graz, Austria) with multiple intra-abdominal abscesses and peritonitis. He had undergone an appendectomy in Pristina, Kosovo, in April 2010, after which abdominal sepsis developed. His travel history was completely unremarkable. On the day of admission, multiple-drug resistant K. pneumoniae was isolated from 5 sites (2 swab samples from the abdominal wound, 1 sample from the throat, 1 sample of secretion from an abdominal fi stula, and 1 sample from stool). As of November 2010, the patient still required medical care and remained hospitalized.
Most plasmids with the carbapenemase enzyme bla NDM-1 were shown to be readily transferable and prone to rearrangement, which indicates a potential to spread among bacterial populations (3 To the Editor: Carbapenems are often the recommended treatment for serious infections caused by extended-spectrum β-lactamase-producing enterobacteria. However, enzymemediated carbapenem resistance is increasingly reported worldwide. Carbapenemases are represented by 3 molecular classes of β-lactamase: A, B, and D (1). The best known class A carbapenemase is Klebsiella pneumoniae carbapenemase (KPC); KPC-producing enterobacteria are responsible for many hospital outbreaks. Class B carbapenemases are metallo-β-lactamases (MBL), which have the widest substrate spectrum. Class D OXA-type carbapenemases are found mainly in nonfermenting bacteria, except for OXA-48, which has been found only in enterobacteria.
In Hong Kong Special Administrative Region, People's Republic of China, the Public Health Laboratory Centre routinely provides microbiological diagnostic services for government outpatient clinics and confi rms the identity of bacterial isolates referred by other clinical laboratories. In 2009, among 18 enterobacteria isolates determined to be not susceptible to carbapenem, only 4 isolatesCitrobacter freundii, Enterobacter cloacae, Escherichia coli, and K. pneumoniae-were confi rmed to produce carbapenemase. The E. coli isolate was from a government outpatient clinic; the others were from a regional hospital laboratory (Table) .
For all 4 isolates, the modifi ed Hodge test (2) demonstrated enzyme activity against ertapenem and meropenem. Previously described PCR and sequencing methods (1) identifi ed the MBL IMP-4 in the C. freundii and K. pneumoniae isolates; the C. freundii isolate also possessed extended-spec- 
